The 2025 ESC/EACTS update redefines the boundaries between surgery and transcatheter therapy. It advocates earlier intervention in severe aortic stenosis, lowers the age threshold for TAVI to 70 years, expands the use of MitraClip to lower-risk scenarios, promotes percutaneous tricuspid treatment, and grants a new central role to advanced imaging in decision-making.

Prospective observational study evaluating 5-year clinical outcomes of transcarotid TAVR in moderate-to-high surgical risk patients with no viable femoral access.

This summary updates the indications for intervention in aortic regurgitation (AR) according to the 2021 ESC/EACTS guidelines, with a practical and clinically oriented perspective.

We review the indications for intervention in aortic stenosis (AS) according to the 2021 ESC/EACTS Guidelines, offering a practical perspective on how to apply these recommendations in real-world surgical settings. Additionally, we analyze recent evidence that may anticipate significant updates in future guideline revisions.

Surgical commentary on transcatheter aortic valve explantation in settings of dysfunction and endocarditis, based on videos published in the Multimedia Manual of Cardio-Thoracic Surgery and CTSNet, along with recent technical articles addressing reproducible surgical strategies to avoid complete aortic root replacement and to manage these increasingly common cases with greater safety.

Retrospective observational study evaluating a modified surgical technique for sutureless Perceval valve implantation aimed at reducing the need for permanent pacemaker implantation (PPI) by displacing the membranous septum.